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A set of monomeric near-infrared ﬂuorescent
proteins for multicolor imaging across scales
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Francesca Pennacchietti2, Anton A. Shemetov1, Ilaria Testa 2 & Vladislav V. Verkhusha 1,3*
Bright monomeric near-infrared (NIR) ﬂuorescent proteins (FPs) are in high demand as
protein tags for multicolor microscopy and in vivo imaging. Here we apply rational design to
engineer a complete set of monomeric NIR FPs, which are the brightest genetically encoded
NIR probes. We demonstrate that the enhanced miRFP series of NIR FPs, which combine high
effective brightness in mammalian cells and monomeric state, perform well in both
nanometer-scale imaging with diffraction unlimited stimulated emission depletion (STED)
microscopy and centimeter-scale imaging in mice. In STED we achieve ~40 nm resolution in
live cells. In living mice we detect ~105 ﬂuorescent cells in deep tissues. Using spectrally
distinct monomeric NIR FP variants, we perform two-color live-cell STED microscopy and
two-color imaging in vivo. Having emission peaks from 670 nm to 720 nm, the next gen-
eration of miRFPs should become versatile NIR probes for multiplexed imaging across spatial
scales in different modalities.
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Imaging in the near-infrared (NIR) part of the spectrum withNIR ﬂuorescent proteins (FPs) has several advantages overimaging with traditional visible FPs. In a NIR (~650–900 nm)
optical window, the tissue is more transparent to light due to less
absorbance by body pigments and less scattering1. This spectral
region is also characterized by low autoﬂuorescence and minimal
phototoxicity for living cells. Thus, NIR FPs have been used for
quantitative imaging in deep tissues in vivo2. Also, a use of distant
NIR spectral region for imaging allows combination of NIR FPs
in multiplexed experiments with visible FP tags, biosensors and
optogenetic tools controlled by 450–600 nm light without cross-
activation3. Thus, NIR FPs are extremely useful for imaging at
various scales, from individual molecules to whole organisms;
however, their potential has not yet been fully explored due to the
lack of NIR FPs that combine all beneﬁcial characteristics, such as
high molecular and effective brightness (also called cellular
brightness), monomeric state, and being spectrally shifted in
relation to each other.
NIR FPs were developed from bacterial phytochromes (BphP)2,4.
These proteins, similar to their precursor BphP photoreceptors,
use a linear tetrapyrrole biliverdin IXα (BV) as a chromophore.
BV is the most red-shifted natural chromophore5,6. Fortunately,
BV is produced in mammalian cells as an intermediate of heme
degradation7. The majority of NIR FPs are composed of two
domains, the PAS and the GAF, minimally required for BV
chromophore binding in BphPs8. BV sits in the pocket in the
GAF domain, whereas the PAS domain covalently binds BV via
Cys residue and is needed for stabilization of the whole struc-
ture9,10. In the blue-shifted NIR FPs, BV was found being cova-
lently bound to Cys in the GAF domain11,12. Interestingly, the
PAS and the GAF domains form a topological knot structure with
the N-terminus being threaded through the loop in the GAF
domain8,13. Although a single-domain NIR FP based on the GAF
domain of cyanobacteriochrome (CBCR) was developed, the
current probe named miRFP670nano yields to two-domain
BphP-based NIR FPs in molecular brightness14.
To date, several series of NIR FPs have been published15–22.
For BphP-based NIR FPs, the apparent brightness of a FP in
mammalian cells is one of the most important properties to be
considered23. Because apoprotein NIR FPs incorporate BV with
different afﬁnities and speciﬁcities, and their expression levels and
protein stabilities vary, their effective brightness varies too and
does not correlate with the molecular brightness. So far NIR FPs
of a near-infraRed Fluorescent Protein (iRFP) series demon-
strated the highest effective brightness compared to other
reported NIR FPs2. The iRFPs were developed in ﬁve spectral
variants, from blue-shifted iRFP670 to red-shifted iRFP720
(the numbers correspond to emission maxima)15. That allowed
use of iRFPs in multicolor NIR imaging and gave researchers an
option to select a NIR FP that best suits their experiment and
imaging setup.
Similarly to their precursor canonical BphPs24, many NIR FPs
are dimers. These include NIR FPs of the iRFP series, which we
developed from Rhodopseudomonas palustris RpBphP2 and
RpBphP6, and FPs of an Infrared Fluorescent Protein (IFP) series
developed from Deinococcus radiodurans DrBphP. Although
IFP1.4 (ref. 17) and IFP2.0 (refs. 18,25) were originally reported as
monomers, later they were found to form dimers and aggregates
when used in protein fusions2,19.
The dimerization interface in NIR FP dimers is located in the
C-terminal α-helixes of the GAF domain20. Therefore, mono-
merization of NIR FPs, mostly obtained from canonical dimeric
BphPs, was performed by disruption of the dimeric interface by
changing respective hydrophobic amino acid residues in the C-
terminus to charged ones. The problem with this approach is that
the resulting monomerized NIR FPs, such as Wi-Phy20, IFP1.417,
and IFP2.018, had relatively poor effective brightness in mam-
malian cells and/or still formed dimers, limiting their use as
protein tags2. A use of precursor non-canonical BphPs, such as
Bradyrhizobium phytochrome (BrBphP) and RpBphP1, which do
not dimerize through the C-terminal α-helixes in the GAF
domain and naturally contain charged residues in the C-termi-
nus, allowed to engineer the ﬁrst and until recently the only
available monomeric NIR FPs, such as mIFP19 and three
miRFPs16, which fully rely on endogenous BV to ﬂuoresce in
mammalian cells.
mIFP and miRFPs were used in various protein fusions,
including cytoskeletal ﬁlaments, and simultaneously imaged with
FPs of green ﬂuorescent protein (GFP) family. However, mIFPs
suffer from low effective brightness in mammalian cells and poor
photostability. miRFPs were shown to be several-fold brighter16.
These FPs were used for development of NIR reporters and
biosensors, including miSplit for ﬂuorescence complementation
assay of protein–protein interaction and RNA imaging, NIR
reporter for NF-κB signaling, NIR cell cycle reporters and NIR
Rac1 FRET biosensor16,26. While miRFPs have highest molecular
and effective brightness among monomeric NIR FPs, they yield to
dimeric iRFPs having 1.5–3-fold lower effective brightness in
mammalian cells. The only monomeric NIR FP that reached the
effective brightness of dimeric iRFPs is recently reported
miRFP720 (ref. 26). However, other spectral variants of bright
monomeric NIR FPs are needed because the excitation maximum
of miRFP720 at 702 nm is suboptimal, being away from common
633–640 nm lasers. Moreover, availability of other spectral var-
iants should enable multicolor imaging in NIR.
Here we aim to develop a set of monomeric NIR FPs suitable
for imaging across spatial scales and that allow researchers to
avoid tradeoffs between high effective brightness and monomeric
state. We achieve monomerization of iRFPs without a loss in
effective brightness. We also further improve available miRFPs by
enhancing their cellular protein stability. We show that the
engineered monomeric NIR FPs perform well as protein tags and
can be efﬁciently used in super-resolution stimulated emission
depletion (STED) microscopy. We then demonstrate that the
same FPs, due to their exceptional effective brightness and NIR
spectra, can be applied for quantitative whole-body imaging in
living mice. Lastly, the availability of several spectral variants
allows multicolor NIR imaging in STED and in vivo.
Results
Monomerization of dimeric iRFPs. We hypothesized that a
homology between BphP-based FPs should allow us to mono-
merize dimeric NIR FPs by transferring charged residues,
potentially responsible for disruption of dimeric interface
between NIR FPs engineered from different natural BphPs
(Supplementary Fig. 1). The similar approach was shown to be
successful for engineering of miRFP720 (ref. 26). Therefore, to
monomerize iRFPs obtained from RpBphP2 and RpBphP6, we
made an alignment of the PAS–GAF domains of these BphPs
with RpBphP1-derived miRFPs and introduced the amino acid
residues 300K/301R/304E/305R/308T from miRFPs into the
respective positions in iRFPs (Fig. 1a, b). To obtain spectrally
distinct FPs, we monomerized in this way RpBphP2-based
iRFP713, iRFP682 and iRFP713/V256C, and RpBphP6-derived
iRFP670 and iRFP702. Compared to iRFP682 (ex. 663 nm, em.
682 nm), iRFP713/V256C was previously found to be spectrally
similar (ex. 662 nm, em. 680 nm) but having 1.5-fold higher
effective brightness27.
We tested performance of the monomerized FPs in protein
fusions. Since the C-termini are the same in FPs from each of the
RpBphP families, we tested one representative FP from each group,
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RpBphP2-derived miRFP713 and RpBphP6-derived miRFP670–2,
in ﬁlamentous cytoskeletal fusions with tubulin (α-tubulin) and
LifeAct (Fig. 1c and Supplementary Figs. 2–7). While fusions with
original dimeric iRFP713 and iRFP670 proteins showed high
percentage of expression artifacts, the fusion constructs with
miRFP713 and miRFP670-2 showed correct intracellular localiza-
tion and no aggregates, as expected from monomeric FP tags.
Moreover, we analyzed signal-to-background ratios for wideﬁeld
images of miRFP713-tubulin fusion and similar fusions of the well-
established monomeric proteins EGFP and mCherry and found
that they are comparable (Supplementary Fig. 8). Analytical
ultracentrifugation has further conﬁrmed the monomeric state of
the monomerized iRFPs (Supplementary Fig. 9).
We next tested effective brightness of the monomerized iRFPs,
miRFP670-2, miRFP702, miRFP680 (obtained from iRFP713/
V256C), miRFP682, miRFP713, and reported before miRFP720
alongside dimeric iRFPs, RpBphP1-derived miRFPs and BrBphP-
derived mIFP (Fig. 1d). We found that the RpBphP2-derived
miRFPs had similar effective brightness as their dimeric
precursors. The RpBphP6-derived miRFPs exhibited ~50%
decrease in the effective brightness as compared to the precursors.
Therefore, bright monomeric NIR FPs, spectrally analogous to
(m)iRFP670 and iRFP702/miRFP703 were still needed.
Engineering of enhanced miRFPs (emiRFPs). To increase the
effective brightness of miRFP703, we applied directed molecular
evolution consisting of random mutagenesis followed by selection
of the brightest clones in bacterial and mammalian cells. We
obtained several clones with slight improvement in effective
brightness in mammalian cells (less than 50%), which all con-
tained mutations of different amino acid residues in the N-
terminus with no obvious pattern. The N-terminus of BphP-
based NIR FPs, including miRFPs, is unstructured and cannot be
visualized on a protein structure11,12. It is not conserved (Fig. 2a
and Supplementary Fig. 10a) and can be shortened almost up to
the chromophore binding Cys in fusion constructs without sub-
stantial loss of ﬂuorescence. However, the N-terminus of the PAS
domain is threaded through the ﬁgure-of-eight loop in the GAF
domain, forming a knot structure9. Therefore, it should be
important for the folding and stability of the whole protein
structure.
We decided to study an effect of N-terminus on effective
brightness of miRFP703 systematically. For this, we removed
amino acid residues at the N-terminus one by one and compared
the brightness of the obtained variants in mammalian cells.
Surprisingly, we found that the variant without the ﬁrst 13 amino
acid residues was the brightest showing more than 3-fold increase
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Fig. 1 Monomerization of dimeric miRFPs. a Dimerization interface in RpBphP2-derived iRFPs. The residues substituted based on alignment with RpBphP1-
derived miRFPs are in yellow. The BV chromophore is in blue. The model is based on RpBphP2-PAS-GAF structure (PDB ID: 4R6L). b Alignment of C-
termini from parental BphPs, i.e. RpBphP1, RpBphP2 and RpBphP6, monomeric RpBphP1-derived miRFPs, and monomerized iRFPs of RpBphP2 and RpBphP6
origins. The substituted residues are marked in yellow. c Fusions of miRFP713 (representative monomerized iRFP derived from RpBphP2) and miRFP670–2
(representative monomerized iRFP derived from RpBphP6) labeling actin (LifeAct) and tubulin in live HeLa cells. Scale bar, 10 µm. d Brightness of
monomerized iRFPs in comparison with dimeric iRFPs and previously reported monomeric NIR FPs. Columns are highlighted according to the origin of NIR
FPs (RpBphP2-derived FPs in red, RpBphP6-derived in green and RpBphP1-derived in cyan) and their oligomeric state (dimeric are dashed, monomeric are
plain). Error bars are double s.e.m. (n= 3; transfection experiments).
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in effective brightness in HeLa cells, compared to the original
miRFP703 (Fig. 2b). Based on alignment (Fig. 2a), we shortened
N-termini in miRFPs of RpBphP2 and RpBphP6 origins and
mIFP of BrBphP origin, leaving ﬁve amino acid residues before
the chromophore-binding Cys, as in RpBphP1-derived
miRFP703. However, these variants did not demonstrate any
improvement in effective brightness (Supplementary Fig. 10).
Moreover, we tested and observed similar increase in effective
brightness for truncated miRFP670 and miRFP703 and no
improvement for truncated NIR FPs of other BphP-origins in
different mammalian cell lines, such as HeLa, COS-1 and
NIH3T3 (Supplementary Fig. 10). We concluded that it is not
the length of the N-terminus but the presence of a speciﬁc amino
acid sequence in the RpBphP1-derived N-terminus leads to the
decrease of effective brightness in cells.
The observed decrease in the effective brightness should result
from a decrease in the number of functional FP molecules per
cell, because the N-terminus is located outside of the
chromophore-binding pocket at the surface and should not
inﬂuence the molecular brightness or chromophore binding
efﬁciency. We tested how incubation with inhibitors of protein
synthesis and degradation affects the effective brightness of
miRFP670 and miRFP703 and their truncated versions (Fig. 2c).
Inhibition of proteasome by bortezomib resulted in an increase in
effective brightness by at least 40% for original miRFPs, whereas
almost no change was observed for the truncated versions.
Inhibition of the protein synthesis by cycloheximide resulted in
the larger decrease in effective brightness of original miRFPs
(30%), as compared to the truncated miRFPs (10%). We
concluded that the N-terminus of the RpBphP1-based proteins
promotes degradation of miRFPs.
We hypothesized that the N-terminus can be transferred from
a stable bright NIR FP to the RpBphP1-derived miRFPs to
increase their cellular stability in cells and, consequently, effective
brightness. We chose to transfer the N-terminus from RpBphP2,
since we observed a decrease in the brightness when it was
removed from RpBphP2-derived miRFP720 (Supplementary
Fig. 10). We replaced the original N-terminus in miRFP670 and
miRFP703 with the whole RpBphP2-based N-terminus preceding
the chromophore-binding Cys. We compared effective brightness
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Fig. 2 Engineering of enhanced miRFPs. a Alignment of N-termini of monomeric NIR FPs derived from RpBphP1 and RpBphP2. b Effective brightness of
miRFP703 variants with 12–16 amino acid residues removed from the N-terminus. Analysis was performed in COS-1 cells using ﬂow cytometry 72 h after
transfection. The effective brightness of the original miRFP670 was assumed to be 100% for normalization. c Effective brightness of miRFP670 and
miRFP703 and their variants with 13 amino acid residues removed from N-terminus in control cells and after 4 h incubation with 10 µM proteasome
inhibitor bortezomib or 50 µg ml−1 ribosome blocker cycloheximide in live COS-1 cells. Error bars, double s.e.m. (n≥ 3; transfection experiments).
Brightness of FPs in control cells was assumed to be 100% for normalization. d Effective brightness of miRFP670 and miRFP703, their variants with 13
amino acid residues removed from N-terminus, and their variants with N-termini of RpBphP2. Measurements were performed in COS-1 cells 72 h after
transfection. Effective brightness of miRFP720 was assumed to be 100% for normalization.
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of miRFP670 and miRFP703 having original N-termini, ones
shortened by 13 a.a. residues or ones with substituted RpBphP2
N-terminus (Fig. 2d). Seventy-two hours after transfection, the
effective brightness of the constructs with N-terminus of
miRFP720 was up to 30% higher compared to the shortened
constructs. We tested and conﬁrmed the similar increase in the
effective brightness for miRFP670 and miRFP703 with the
RpBphP2 N-terminus in different cell lines, such as COS-1,
HeLa and NIH3T3 (Supplementary Fig. 11). We also exchanged
the N-terminus in RpBphP6-derived miRFP670–2 and miRFP702
for the RpBphP2 N-terminus; however, we did not observe an
increase in the effective brightness (Supplementary Fig. 12a).
We named the miRFP670 and miRFP703 variants with
RpBphP2 N-terminus as emiRFP670 and emiRFP703, respec-
tively, where “e” stands for enhanced. To conﬁrm that emiRFPs
exhibit the increased effective brightness due to the increased
protein stability, we measured a change in the brightness over
time in transiently transfected COS-1 cells (Supplementary
Fig. 12b). Ninety-six hours after transfection, the cells expressing
original miRFP670 and miRFP703 lost ~40–50% of ﬂuorescence
signal as compared to 48 h, whereas the cells expressing emiRFPs
lost 10–20% only.
Properties of the engineered monomeric NIR FPs. Molecular
brightness (the product of a molar extinction coefﬁcient and a
quantum yield), pH stability and photostability of the mono-
merized iRFPs were similar to those of their parental iRFPs
(Table 1), with an exception of miRFP680 that exhibited twice
higher photostability. Apparently, the amino acid substitutions in
the dimerization interface had little effect on the chromophore
microenvironment in miRFP670–2, miRFP682, miRFP702 and
miRFP713. The developed enhanced emiRFP670 and emiRFP703
had these characteristics similar to the parental miRFP670 and
miRFP703 too as expected, because the substituted N-terminus is
located on the protein surface outside of the chromophore pocket.
To test the performance of emiRFPs as protein tags in various
intracellular structures, we generated a set of constructs including
C-terminal fusions of emiRFP703 with tubulin, myosin and
clathrin, and N-terminal fusions with H2B, zyxin and vimentin
(Fig. 3a–f and Supplementary Figs. 13–15). In all fusion
constructs, the tagged proteins demonstrated correct localization
in live cells, similar to localization of the similar EGFP and
mCherry fusion constructs (Supplementary Figs. 13–15). We next
compared the effective brightness of the emiRFP703 fusions with
the similar fusions of parental miRFP703 (Fig. 3g). All cells with
the emiRFP703 fusion constructs were brighter, having more
prominent increase over the parental miRFP703 fusions for the
C-terminal emiRFP703 fusions.
emiRFPs in super-resolution STED microscopy (nanometer
scale). Super-resolution live-cell imaging calls for development of
FPs that are sufﬁciently bright and allow efﬁcient photoswitching
or STED, thus requiring less illumination power for imaging.
They should also be photostable to withstand multiple cycles of
illumination.
Here we show that the emiRFP670 and emiRFP703 can be used
for super-resolution imaging of cellular fusions with different
proteins such as LAMP1 in lysosomes, H2B in the nucleus,
vimentin, clathrin in endosomes, tubulin and myosin (Supplemen-
tary Fig. 16). Moreover, the brightness and spectral properties of
emiRFP670 and emiRFP703 allow imaging by a standard 640 nm
excitation laser that is readily available on most commercial
confocal and even super-resolution microscopes. Previously, we
demonstrated imaging of miRFP703 in structure-illumination
microscopy (SIM) in ﬁxed cells doubling the spatial resolution
achievable with conventional techniques16.
Here, to further overcome the diffraction limit (~230 nm for
NIR FPs), and visualize cellular structures at 40–50 nm scale, we
use STED microscopy for imaging spectrally distinct emiRFP
variants (Fig. 4, Supplementary Fig. 18). The advantage of using
STED in the NIR spectral range is the lower-energetic light of
such wavelength, allowing focusing of a high power (10–25mW)
STED beam on living cells for achieving the highest spatial
resolution. Still, a current challenge in performing STED imaging
with previously available NIR probes is to increase the signal and
to use even lower STED intensities. The beneﬁcial properties of
emiRFPs as bright and photostable NIR tags make them suitable
candidates for STED imaging.
We used 640 nm and 775 nm laser light for excitation and
STED, respectively. It is important to note that the use of bright
NIR emiRFPs and red-shifted lasers allowed imaging of living
cells. STED microscopy allowed distinguishing small structures,
Table 1 Spectral and biochemical properties of the currently available BphP-derived monomeric NIR FPs.
Monomeric NIR FP Parental BphP Ex, nm Em, nm Extinction
coefﬁcient,
M−1cm−1
Quantum
yield, %
Molecular
brightness
vs.
miRFP720,
%a
Photostability
in mammalian
cells, t1/2, s
pKa Eff.
brightness
in HeLa
cells vs.
miRFP720,
%b
Reference
miRFP670 RpBphP1 642 670 87,400 14.0 204.7 490 4.5 67.9 16
miRFP670–2 RpBphP6 643 670 103,000 13.6 234.3 310 4.5 80.8 This paper
emiRFP670*c RpBphP1 642 670 87,400 14.0 204.7 450 4.5 117.0
miRFP680* RpBphP2 661 680 94,000 14.5 228.0 980 4.5 156.7
miRFP682 RpBphP2 663 682 91,000 11.2 170.5 500 4.5 101.8
miRFP702 RpBphP6 673 702 88,000 8.1 119.2 640 4.5 40.6
miRFP703 RpBphP1 674 703 90,900 8.6 130.8 650 4.5 49.8 16
emiRFP703* RpBphP1 674 703 90,900 8.6 130.8 700 4.5 77.6 This paper
mIFP BrBphP 683 705 65,900 6.9 76.1 90 4.5 13.9 19
miRFP709 RpBphP1 683 709 78,400 5.4 79.8 500 4.5 29.0 16
miRFP713* RpBphP2 690 713 99,000 7.0 115.9 980 4.5 94.9 This paper
SNIFP DrBphP 697 720 149,000 2.2 54.8 n.a. 4.5 n.a. 33
miRFP720* RpBphP2 702 720 98,000 6.1 100.0 510 4.5 100 26
aMolecular brightness is a product of extinction coefﬁcient and ﬂuorescence emission quantum yield
bDetermined as a mean NIR ﬂuorescence intensity of HeLa cells 48 h after transfection with no supply of exogenous BV
cA set of ﬁve spectrally distinct monomeric NIR FPs, which is recommended for further use in imaging applications, is marked with asterisks
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like ﬁlaments in close proximity, clathrin-coated pits as hollow
structures and myosin periodic structures, not resolvable in the
conventional confocal image. Using the data shown in Fig. 4 and
additional analysis on spatial resolution on tubulin ﬁlaments
(Supplementary Fig. 17), we were able to visualize structures with
a full-width half-maximum (FWHM) of 41 nm, and routinely
achieving a spatial resolution of 50–70 nm. Importantly, this is
comparable to a typical resolution obtained with established
STED probes, such as SiR-tubulin dye28,29 (Supplementary
Fig. 19, Supplementary Table 1 and Supplementary Note 1) and
was achieved with half the STED illumination dose.
As STED imaging requires photostable FPs, we directly tested
how many consecutive frames can be obtained without a
substantial loss in brightness (Fig. 5). For confocal microscopy,
we could detect 1500 frames before the FP brightness decreased in
half. For STED, 20 frames could be obtained before the FP
brightness decreased in half, and more than 50 frames could be
imaged without a loss in image quality. Thus, emiRFPs perform
well in comparison with previously reported far-red FPs in terms
of photostability and allow use of substantially lower STED
illumination dose (11–36-fold lower than for other far-red FPs)
(Supplementary Table 2 and Supplementary Note 1).
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Fig. 4 Live-cell STED imaging of emiRFP670 and emiRFP703 fusions. a Confocal and STED images of HeLa cells expressing emiRFP670-tubulin.
#1 shows a line proﬁle from the zoomed-in region of interest, and shows two tubules 141 nm apart, which cannot be distinguished in the confocal image. b
Confocal and STED images of U2OS cells expressing LAMP1-emiRFP670. #2 shows a line proﬁle across a lysosome with a diameter of 189 nm and a clearly
resolved membrane in the STED data (red solid line). c Confocal and STED images of U2OS cells expressing H2B-emiRFP670. #3 is a line proﬁle across a
region of the nucleus, which shows several structures not resolvable in the confocal image. d Confocal and STED images of HeLa cells expressing vimentin-
emiRFP703. #4 shows a line across three ﬁlaments in close proximity, which are not resolved in the confocal image. e Confocal and STED images of HeLa
cells expressing emiRFP703-clathrin. #5 shows a line proﬁle across a small clathrin-coated pit, only visible in the STED data. Line proﬁle is 1 pixel wide. f
Confocal and STED images of U2OS cells expressing emiRFP703-myosin. #6 shows a line proﬁle across several myosin densities in close proximity, which
look homogeneous in the confocal image of the same structure. Line proﬁles are taken from the raw images, and averaged over a width of 3 pixels unless
otherwise stated. A Gaussian was used to ﬁt the confocal data (black solid line) and a Lorentzian to ﬁt the STED data (red solid line). Scale bars are 2 µm
for the full images and 500 nm for the inserts showing the zoomed-in regions of interest.
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Having spectrally distinct emiRFPs further opens a possibility
for a multiplexed imaging. We imaged co-expressed vimentin-
emiRFP670 and H2B-emiRFP703 or emiRFP703-clathrin by two-
color STED in living cells (Fig. 6). STED imaging was performed
with two excitation lasers, 585/610 nm for emiRFP670 and
670 nm for emiRFP703, and two emission detection channels,
625–660 nm for emiRFP670 and 710–755 nm to collect
emiRFP703 emission. The images were recorded in a line-by-
line alternating fashion for the two spectrally separated channels.
The ﬂuorescent signal of each emiRFP was either directly
spectrally separated in the imaging or extracted by using spectral
unmixing since the emission spectra of emiRFP670 slightly
overlaps with that of emiRFP703. Thus, we demonstrate the
possibility of a two-color STED imaging in the NIR spectral range
with two FPs.
emiRFPs in whole-body imaging in living mice (centimeter
scale). We next tested the performance of emiRFPs as markers for
non-invasive whole-body imaging. First we compared the
brightness of emiRFPs with parental miRFPs in vivo. For this, we
implanted the same amounts of COS-1 cells expressing the
respective NIR FPs in mammary glands of mice. The NIR
ﬂuorescence signals were normalized to bioluminescence of co-
expressed Rluc8 to account for transfection efﬁciency and cell
quantity. The brightness of the emiRFP-expressing cells in vivo
was ~2.8-fold higher than that of the respective parental miRFP
cells (Fig. 7a, b), consisting with the COS-1 imaging in cell culture
(Fig. 2d).
We then assessed the minimal detectable number of the
implanted cells expressing emiRFPs. For this, we injected in
mammary glands various amounts of transfected cells and found
that we were able to detect 1.2 × 105 and 1.0 × 105 ﬂuorescent cells
for emiRFP670 and emiRFP703, respectively (Fig. 7c, d).
We next explored the spectral diversity of emiRFP670 and
emiRFP703 and tested them for simultaneous imaging of two
cellular populations in vivo. Cells transfected with either
emiRFP670 or emiRFP703 were well spectrally resolved in living
mice by applying the standard spectral unmixing algorithm in an
IVIS Spectrum imaging system (Fig. 7e).
Discussion
We have developed several spectrally distinct bright monomeric
NIR FPs, proposed as the expanded set for various imaging
applications, from microscopy to in vivo imaging. This set
consists of the brightest FP versions reported in this work, such as
emiRFP670, miRFP680, emiRFP703, miRFP713 and reported
earlier miRFP720 (ref. 26). Under the common standard condi-
tions (HeLa cells, 48 h after transfection), the engineered miRFPs
are up to 1.7-fold brighter than dimeric iRFPs15 (Fig. 8) and
almost 2-fold brighter than previously published miRFPs
(Table 1).
For engineering of the miRFPs, we explored the homology
between NIR FPs and were able to transfer beneﬁcial sequences in
respective protein structure elements between NIR FPs of dif-
ferent BphP origins. We suggest that the method of the NIR FP
monomerization by transferring of the speciﬁc amino acid resi-
dues from the C-terminal α-helix of RpBphP1-derived miRFPs to
the C-termini of other NIR FPs performed in this work is uni-
versal and can be applied for monomerization of dimeric NIR FPs
of any BphP origin with a minimal loss in effective brightness in
mammalian cells.
To increase the effective brightness of RpBphP1-derived
miRFPs, we exchanged their original N-terminus with the N-
terminus from RpBphP2. Our results (Figs. 2, 3 and Supple-
mentary Figs. 10–12) indicate that the RpBphP1-derived N-ter-
minus contains the sequence that causes an increased protein
degradation by proteasome. However, computer analysis did not
allow us to identify this sequence. There were no lysine residues
and, consequently, no potential sumoilation and ubiquitination
sites. Clearly, the N-terminus of any BphP-derived NIR FP affects
protein stability in cells. That is expected because the N-terminus
of the PAS domain is threaded through the loop in the GAF
domain forming a knot structure. Moreover, this knot is tigh-
tened by a covalent binding of BV located in the GAF domain to
the Cys that is located right after the N-terminus in the PAS
domain. The importance of the stability of the whole protein
structure for denaturation and its correlation with the effective
brightness were acknowledged previously27.
Enhanced emiRFP670 and emiRFP703 combine monomeric
state, exceptional effective brightness, and good photostability,
making them suitable ﬂuorescent tags for live-cell STED micro-
scopy. STED imaging requires a relatively high-power STED
beam to conﬁne the emission signal to a sub-diffraction-sized
volume30,31, which can be potentially toxic to cells. STED with
far-red, or better, NIR FPs minimizes this risk32. Bright mono-
meric emiRFPs satisfy the requirements of low toxicity to cells
and high photostability, enabling NIR STED imaging of live cells.
We demonstrated STED imaging of the emiRFP fusions with a
resolution approaching 40 nm (Fig. 4 and Supplementary Fig. 17).
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Fig. 5 Confocal and STED time-lapse imaging of vimentin-emiRFP703. a, b A confocal image series (a) and c, d a STED image series (c) of live HeLa cells
transfected with emiRFP703-vimentin. The graphs (b, d) show the normalized integrated intensity of the recorded frames (red circles) for both image
series, plotted every 40th frame for the confocal for better visualization (b) and every frame for STED (d). The displayed intensity scale has been adjusted
per frame from zero to the maximum in respective frame. Scale bars, 2 µm.
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The brightness of the optimized emiRFPs allowed to perform NIR
STED with the widely used 640 nm excitation laser and without
addition of exogenous BV chromophore, in contrast to STED
performed earlier with SNIFP protein with low quantum yield
(2.2%) of DrBphP origin33. The NIR FPs are excited at or close to
their peak by 640–670 nm lasers. In contrast, the far-red GFP-like
FPs previously used for live-cell STED, such as E2-Crimson34,
mGarnet35, TagRFP65736 and mNeptune237,38, have to be excited
at the red edge of their spectrum. Moreover, the far-red FPs suffer
from lower photostability, allowing to take no more than 20
consecutive frames without loss in image quality35,39, as com-
pared to 50 frames obtained with emiRFPs. Furthermore, the
distinct excitation and emission spectra of emiRFP670 and
emiRFP703 enabled two-color NIR STED with FPs, which before
was only possible with organic ﬂuorophores40.
In addition to multicolor super-resolution microscopy, the
most popular application of NIR FPs is in vivo imaging2. We
validated the performance of emiRFPs in living mice. The cells
expressing emiRFPs produced several-fold brighter ﬂuorescence
signal 1–2 mm deep in mouse tissues than the cells with parental
miRFPs. The minimal number of detectable cells 105 is com-
parable or even lower than previously reported detection limits
for NIR FPs14,41. Spectral difference between emiRFP670 and
emiRFP703 allowed their two-color imaging in vivo.
We envision that the proposed set of ﬁve spectrally distinct
monomeric NIR FPs, consisting of emiRFP670, miRFP680,
emiRFP703, miRFP713 and miRFP720 (ref. 26), should replace
the spectrally similar dimeric iRFPs as the state-of-the-art
genetically encoded NIR probes. The enhanced miRFPs should
become versatile protein tags and building blocks for biosensors,
thus, opening broad possibilities for multicolor NIR imaging at
both subcellular and organismal scales.
Methods
Design of plasmids. To generate plasmids encoding the monomerized NIR FPs,
site-speciﬁc mutagenesis was performed with QuikChange mutagenesis kit (Agilent
Technologies). Similarly, the constructs encoding the emiRFPs and miRFP variants
with shortened N-termini were generated using QuikChange mutagenesis kit.
Escherichia coli TOP10 bacteria strain (Invitrogen) was used for transformation.
The mIFP-N1 (#54620), mCherry-tubulin (#55148), vimentin-EGFP (#56439),
vimentin-mCherry-N1 (#55158) and H2B-mCherry (#20972) encoding plasmids
were obtained from Addgene.
For protein tagging and labeling of intracellular structures study, the fragments
encoding emiRFPs were ampliﬁed, digested with AgeI and NotI restriction
enzymes and ligated with similarly digested cloning vectors for N-terminal fusions
(for H2B, vimentin and zyxin) as previously described16. For C-terminal fusions
(tubulin, clathrin and myosin), the substitution was introduced with QuikChange
mutagenesis kit. See Supplementary Table 3 for sequences of the primers used in
this study.
a b
c d
Fig. 6 Two-color STED imaging of emiRFP670 and miRFP703 fusions. a STED image of a live U2OS cell expressing vimentin-emiRFP670 (cyan) and
H2B-emiRFP703 (orange). Scale bar, 10 µm. b Three zoom-ins of the regions of interest #1–3 from image a. Scale bars, 2 µm. c STED image of a live U2OS
cell expressing vimentin-emiRFP670 (cyan) and emiRFP703-clathrin (orange). Scale bar, 5 µm. d Three zoom-ins of the regions of interest #4–6 from
image c. Scale bars, 1 µm.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13897-6
8 NATURE COMMUNICATIONS |          (2020) 11:239 | https://doi.org/10.1038/s41467-019-13897-6 | www.nature.com/naturecommunications
Protein characterization in vitro. For expression in bacteria, the miRFPs were
cloned into pBAD/His-B vector (Life Technologies/Invitrogen). LMG194 or
TOP10 host cells (Invitrogen) were used for protein expression. A pWA23h
plasmid encoding HO from Bradyrhizobium ORS278 (hmuO) under the rhamnose
promoter was co-transformed with a pBAD/His-B plasmid encoding a FP. Bac-
terial cells were incubated overnight at 37 °C in RM minimal medium with
ampicillin and kanamycin. To start protein expression, 0.002% arabinose and
0.02% rhamnose were added. After growing for 12 h at 37 °C, the cells were
incubated at 18 °C for 24 h. Proteins were puriﬁed with Ni-NTA agarose (Qiagen).
For elution, PBS containing 100 mM EDTA was used instead of imidazole. Then
the samples were desalted using PD-10 desalting columns (GE Healthcare).
For recording of ﬂuorescence and absorbance spectra, FluoroMax-3
spectroﬂuorometer (Jobin Yvon) and Hitachi U-2000 spectrophotometer were
used, respectively. For determination of extinction coefﬁcient, we obtained a ratio
between the maximum absorbance of the main peak at Q band and the side peak at
Soret band and assumed that extinction coefﬁcient at Soret band corresponds to
39,900M−1 cm−1 (refs. 17,22). For determination of quantum yield, we measured
ﬂuorescence spectra of puriﬁed proteins in parallel with an equally absorbing Nile
blue dye (quantum yield is 0.27 in an acidic ethanol25) and previously developed
dimeric iRFPs and compared the signal at several dilutions. pH titrations were
done using a series of buffers (100 mM sodium acetate, 300 mM NaCl for pH
2.5–5.0 and 100 mM NaH2PO4, 300 mM NaCl for pH 4.5–9.0). For determination
of photostability, FPs in transiently transfected HeLa cells were imaged at different
time periods, as described in the wideﬁeld ﬂuorescence microscopy section.
Obtained raw data were normalized to corresponding absorbance spectra and
extinction coefﬁcients of the proteins, the spectrum of 200W Me-Ha arc lamp and
the transmission of 665/45 nm photobleaching ﬁlter.
Analytical ultracentrifugation was conducted at 20 °C and 58,000 r.p.m. with an
Optima XL-I centrifuge (Beckman Coulter) using the AN-60Ti rotor and the
absorption optics set to 645 nm. Sednterp v.20120828beta software was used to
calculate the partial speciﬁc volume of the proteins from their sequence and the
density and viscosity of the buffers. The sedimentation parameters were corrected
to standard conditions (20,w) using these values. For sedimentation velocity (SV)
experiments, 350 ml of protein sample and an equal volume of PBS buffer were
loaded into two-sector cell assemblies with the protein concentration
corresponding to A645 E0.9. Fifty scans were collected over the course of a
centrifuge run. A subset of scans, beginning with those where a clear plateau was
evident between the meniscus and the boundary, was selected for time-derivative
analysis using DCDTþ v.2.4.2 software42.
Cell culture. HeLa CCL-2, HEK293, NIH3T3 and COS-1 cells were obtained from
ATCC and grown in high-glucose DMEM medium (HyClone) containing 10%
(v/v) FBS (Gemini Bio-Products), 0.5% (v/v) penicillin–streptomycin (Mediatech).
All cell lines were grown at 37 °C in a humidiﬁed 5% CO2 atmosphere. Trans-
fection of plasmids was performed with an Effectene reagent (Qiagen) according to
the manufacturer’s protocol. Cells were not tested for mycoplasma contamination
or cross-contamination.
Wideﬁeld ﬂuorescence microscopy. Live HeLa, HEK293, NIH3T3 and COS-1
cells were imaged with an Olympus IX81 inverted epiﬂuorescence microscope 72 h
after the transfection. The microscope was equipped with a 200-W metal halide arc
lamp (Lumen220PRO, Prior), a 60 × 1.35 numerical aperture (NA) oil objective
lens (UPlanSApo, Olympus) and an opiMOS sCMOS camera (QImaging). During
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Fig. 7 Performance of emiRFPs in vivo. a, b Comparison of emiRFP670 with parental miRFP670 (a) and emiRFP703 with parental miRFP703 (b).
Fluorescence (top row) and bioluminescence (bottom row) images of living mice injected with 3 × 106 COS-1 cells expressing emiRFP670 or emiRFP703
(left) and miRFP670 or miRFP703 (right). Cells were co-transfected with Rluc8. The ﬁlter sets were 640/20 nm excitation and 680/30 nm emission (a) or
675/20 nm excitation and 720/30 nm emission (b). Bar plots at the right show quantiﬁed mean ﬂuorescence intensities (normalized to bioluminescence)
that correspond to a and b. Error bars, double s.e.m. (n= 3 experiments). c, d Minimal number of detectable ﬂuorescent cells. Fluorescence (top row) and
bioluminescence (bottom row) images of living mice injected with various quantities of COS-1 cells expressing emiRFP670 (c) or emiRFP703 (d) and co-
transfected with Rluc8. The ﬁlter sets were 640/20 nm excitation and 680/30 nm emission (c) or 675/20 nm excitation and 720/30 nm emission (d).
Transfection efﬁciency of injected COS-1 cells obtained by FACS analysis shown on the right of each panel. e Two-color imaging of emiRFP670 and
emiRFP703. Fluorescence images of living mice injected with 3 × 106 COS-1 cells expressing emiRFP670 (left row) and emiRFP703 (middle row) and its
unmixed overlay (bottom row) are shown. Images were acquired in 19 spectral channels using IVIS Spectrum instrument and spectrally unmixed.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13897-6 ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:239 | https://doi.org/10.1038/s41467-019-13897-6 |www.nature.com/naturecommunications 9
imaging, cells were incubated in a cell imaging medium (Life Technologies-Invi-
trogen) at room temperature. The microscope was operated with a SlideBook
v.6.0.8 software (Intelligent Imaging Innovations).
Flow cytometry. Flow cytometry analysis was performed using a BD LSRII ﬂow
cytometer. All NIR FPs were excited with a 640-nm solid-state laser. Fluorescence
of miRFP670, miRFP670–2, miRFP680 and miRFP682 variants was detected with a
660/20 nm emission ﬁlter, and ﬂuorescence of mIFP, miRFP703, miRFP702,
miRFP713 and miRFP720 variants was detected with a 730/45 nm emission ﬁlter.
Minimally 3 × 105 live cells were analyzed in each cell sample. Data were analyzed
using a FACSDiva v.8.0.1 and a FlowJo v.7.6.2 software.
STED microscopy setup. STED imaging has been performed with a custom-built
STED set-up. The emiRFP-variants were excited with a 640-nm pulsed diode laser
(LDH-D-C-640, PicoQuant) and subsequently depleted with a 775-nm pulsed laser
(KATANA 08 HP, OneFive), both operating at 40 MHz. The depletion beam was
shaped to a donut in the focal plane by the use of a spatial light modulator (LCOS-
SLM X10468–02, Hamamatsu Photonics). The excitation laser and depletion laser
beams were coupled together and scanned over the sample using fast galvanometer
mirrors (galvanometer mirrors 6215H+ servo driver 71215HHJ 671, Cambridge
Technology). The laser beams were focused onto the sample using a HC PL APO
100×/1.40 N.A. Oil STED White objective lens (15506378, Leica Microsystems),
through which also the ﬂuorescence signal was collected. After de-scanning and de-
coupling of the ﬂuorescence signal, it was put through a confocal pinhole (1.28 Airy
disk units) and detected through a bandpass ﬁlter (ET705/100m, Chroma Tech-
nology) and a notch ﬁlter (NF03–785E-25, Semrock) with a free-space APD
(SPCM-AQRH-13-TR, Excelitas Technologies).
An infrared laser (CPS980S, Thorlabs), coupled into the objective with a
dichroic mirror (T860SPXRXT, Chroma Technology) between the scan and tube
lens, is aligned to reﬂect off the coverslip through total internal reﬂection. The
reﬂected laser beam is separated from the incoming beam through a D-shaped
mirror, and imaged onto a CMOS camera (DMK 33UP1300, The Imaging Source
Europe). Through a feedback loop reading the position of the laser beam on the
camera chip and subsequently moving a z-piezo (LT-Z-100, Piezoconcept) holding
the sample, the focus lock system keeps the same desired focal plane in the sample
during acquisitions.
The focus lock and the rest of the microscope is controlled through two separate
software; image acquisition and some hardware control is done through the
Imspector software (Max-Planck Innovation, Göttingen, Germany) while the rest
of the hardware control (SLM, focus lock and 775 nm laser) is done through
Python-based custom-written microscope control software Tempesta (https://
github.com/TestaLab/Tempesta).
STED microscopy. Single-color imaging of emiRFP670 and emiRFP703 was done
with a 640-nm excitation laser power of 5.6–26.1 µW and a 775-nm depletion laser
power of 12–25 mW, both measured at the ﬁrst conjugate back focal plane of the
objective. The pixel size for the STED images was set to 25–30 nm and for the
confocal images 25–30 nm or 100 nm. The pixel dwell time for the STED images
was 5–50 µs and for the confocal images 10 µs.
Two-color STED imaging of emiRFP670 and emiRFP703 was performed with
separation in the excitation and emission. The excitation was done with 585 or
610 nm and 670 nm for the two channels, respectively, while the depletion was
done with 775 nm for both channels. The emission was detected in two separate
channels following respective excitation, with one channel detecting 625–660 nm
and the other detecting 710–755 nm. The 585 or 610 nm excitation laser power
setting was 20–60% while the 670 nm excitation laser power setting was 10–50%.
The depletion laser power setting was 4–15%. The detection signal was gated and
the signal 0.3–6.0 ns after the excitation pulse was recorded. The images were
recorded in a line-by-line alternating fashion for the two spectrally separated
channels.
All images shown are raw data, except images in Fig. 4e (STED and STED
zoom-in) and Fig. 6 (STED and STED zoom-ins) that have been deconvolved with
a Richardson-Lucy deconvolution algorithm in Imspector, using a Lorentzian PSF
with 30–50 nm FWHM. In order to help visualization, we applied a Gaussian
smoothing with 0.6–1 pixel radius (equaling 15–30 nm in STED images) in ImageJ
on images in Fig. 4a (STED zoom-in), Fig. 4b (STED zoom-in), Fig. 4c (STED and
STED zoom-in), Fig. 4d (STED zoom-in), Fig. 4f (STED and STED zoom-in),
Figs. 5c, 6b (confocal zoom-ins) and Supplementary Fig. 16c. Additionally, spectral
unmixing was performed on the two-color STED image in Fig. 6a by using the
ImageJ Spectral Unmixing plug-in from Joachim Walter (https://imagej.nih.gov/ij/
plugins/spectral-unmixing.html).
Cell culture for STED and confocal imaging. Images in Figs. 4–6 and Supple-
mentary Fig. 16 are of U2OS (ATCC HTB-96) and HeLa (ATCC CCL-2) cells,
cultured in Dulbecco’s modiﬁed Eagle medium (DMEM) (Thermo Fisher Scien-
tiﬁc, 41966029) supplemented with 10% (v/v) fetal bovine serum (Thermo Fisher
Scientiﬁc, 10270106) and 1% penicillin–streptomycin (Sigma-Aldrich, P4333), and
kept at 37 °C and 5% CO2 in a humidiﬁed incubator. For transfection with the
emiRFP-variants, cells were seeded on coverslips in a six-well plate. After 24 h, cells
were transfected using Lipofectamine LTX Reagent with PLUS reagent (Thermo
Fisher Scientiﬁc, 15338100) according to the manufacturer’s instructions. About
24–72 h after transfection, cells were washed in phosphate buffered saline (PBS)
solution, placed with phenol-red-free DMEM or Leibovitz’s L-15 Medium (Ther-
moFisher Scientiﬁc, 21083027) in a chamber and imaged at room temperature. In
some cases, BV (Sigma-Aldrich, 30891) was added to the cell medium either 1 h
(Fig. 6c), 2 h (Fig. 4a, f, Supplementary Fig. 16f) or 24 h (Figs. 5a, c and 6a) before
imaging.
Image quantiﬁcation and statistical analysis. Data ﬁtting and statistical analysis
were performed using an OriginPro v.9.2.196 software (OriginLab). Statistical
values including the exact n and statistical signiﬁcance are reported in the
respective Figure legends. Line proﬁle ﬁtting with Lorentzian functions for STED
images and Gaussian functions for confocal images, both including a background
term, were performed using MATLAB (MathWorks).
Imaging in mice. The Swiss Webster 2- to 3-month-old female mice (National
Cancer Institute, NIH) with body weights of 22–25 g were used. To compare
brightness of miRFPs with emiRFPs and show possibility of two-color imaging of
emiRFPs, COS-1 cells were injected subcutaneously in the interscapular area of
Swiss Webster mice. For better imaging, the fur on the bellies of the mice was
removed using a depilatory cream. Mice were fed with AIN-93M Maintenance
Puriﬁed Diet (TestDiet) to reduce the intrinsic autoﬂuorescence level. COS-1 cells
were co-transfected with the pmiRFP670-N1, pmiRFP703-N1, pemiRFP670-N1 or
pemiRFP703-N1 and pRluc8 plasmids in a 9:1 ratio for comparison study using
Effectene (Qiagen). COS-1 cells were transfected with the pemiRFP670-N1 or
pemiRFP703-N1 plasmids for two-color study using Effectene (Qiagen). For
comparison study, 3 × 106 COS-1 cells in 100 μl of RPMI-1640 media supple-
mented with 2 mM L-glutamine were injected subcutaneously 72 h after the
transfection. For studying of detection limit of emiRFPs, various number of cells in
100 μl of RPMI-1640 media supplemented with 2 mM L-glutamine were injected
subcutaneously 72 h after the transfection. For ﬂuorescence and bioluminescence
detection, 1 h after the COS-1 cells injection, the animals were imaged using an
IVIS Spectrum instrument (PerkinElmer/Caliper Life Sciences). Fluorescence was
detected with 640/20 nm excitation and 680/20 nm emission ﬁlters for miRFP670
and emiRFP670 or 675/20 nm excitation and 720/30 nm emission ﬁlters for
miRFP703 and miRFP703. For two-color imaging, spectral unmixing approach was
applied. An image was collected on the IVIS Spectrum with 19 ﬁlter channels.
Bioluminescence was detected with an open emission ﬁlter. Throughout the ima-
ging, animals were maintained under anesthesia with 1.5% vaporized isoﬂurane.
Prior to imaging for comparison and imaging limit studies, 80 μg of Inject-A-Lume
coelenterazine substrate for Rluc8 (NanoLight Technology) was intravenously
injected through a retro-orbital vein. Data were analyzed using Living Image
3.0 software (Perkin Elmer/Caliper Life Sciences).
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Fig. 8 Brightness of the monomeric miRFPs compared to that of
spectrally similar dimeric iRFPs. The effective brightness of (e)miRFPs
(plain) and the respective spectral variants of dimeric iRFPs (dashed) is
shown. The heights of the columns correspond to the mean effective
brightness obtained in HeLa cells 48 h after transfection, normalized to the
brightness of iRFP713. The columns are plotted on the x axis in accordance
with the wavelength of the emission peak of the corresponding NIR FP.
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All animal experiments were performed in an AAALAC-approved facility using
protocols approved by the Albert Einstein College of Medicine Animal Usage
Committee. Twenty mice were used in this study.
Reproducibility. The experiments were not randomized. The investigators were
not blinded to allocation during the experiments and outcome assessment. No
sample-size estimation was performed to ensure adequate power to detect a pre-
speciﬁed effect size.
Reporting Summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The main data supporting the ﬁndings of this study are available within the Article and
its Supplementary materials. The additional data are available from the corresponding
author on reasonable request. The emiRFP670, miRFP680, emiRFP703 and miRFP713
nucleotide sequences in GenBank are MN701051, MN701052, MN701053 and
MN701054, respectively.
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